P: (949) 725-4054
P: (858) 926-3000
F: (949) 823-5054
F: (858) 926-3001
ABOUT JEFF ESTES
Jeffrey A. Estes is a shareholder in Stradling’s Corporate practice group.
Jeff focuses his practice on the representation of public and private companies, including public and private securities offerings, venture capital financings, mergers and acquisitions, regulatory compliance, corporate governance matters, and intellectual property transactions, including licensing and development arrangements.
Jeff has represented many companies in connection with their venture equity and debt financings, including:
- Tandem Diabetes Care Inc.
- WaveTec Vision Systems Inc.
- Vertos Medical Inc.
- Altura Medical Inc.
- M2 Renewables Inc.
He has also represented venture capital funds in their portfolio companies and investments, and has considerable experience and knowledge regarding the issues customary in such transactions.
Recent Speaking Engagements
- “Are Your Contracts Helping or Hurting You?”, OCTANe Legal Roundtable (March 2017)
- “Regulation A+ Making the Grade?”, OC Tech Alliance (September 2015)
Featured Experience
- WaveTec Vision Systems Secures $16.5 Million in Venture Capital FinancingRepresented WaveTec Vision Systems, Inc. in securing $16.5 million in venture capital financing.
- Vessix Vascular Completes Its Sale to Boston Scientific CorporationStradling represented Vessix Vascular in its acquisition by Boston Scientific Corporation for up to $425 million.
- Powerwave Technologies, Inc. Secures Credit Facility With The Gores GroupSenior secured credit facility for Powerwave Technologies, Inc. (Nasdaq: PWAV) with The Gores Group – $50 million.
- Flying L Partners II, LLC Completes Its Investment in RxSight, Inc.Represented Flying L Partners II, LLC with its $25 million investment in Series H Preferred Stock of RxSight, Inc. Bill Link, leader of Flying L Partners’, acted as lead investor through Flying L Partners/RxSight, LLC. RxSight has raised over $46 million in Series H financing.
- Fresca Medical, Inc. Completes Initial Close of Series C Preferred Stock FinancingRepresented Fresca Medical, Inc. with the initial close of its Series C Preferred Stock financing, raising $3.6 million of an anticipated total financing of $6 million. Vincent Medical, Inc. acted as lead investor.
- ReShape Medical, Inc. Secures $11 Million Bridge Loan and New Bank LineRepresented Reshape Medical, Inc. with securing an $11 million bridge loan and a new bank line of credit.
- Interventional Spine, Inc. Completes Sale to DePuy SynthesRepresented Interventional Spine, Inc. in its sale of substantially all of its assets to DePuy Synthes, a subsidiary of Johnson & Johnson (NYSE: JNJ), for an undisclosed price.
- ReVision Optics, Inc. Closes Series F Preferred Stock FinancingRepresented ReVision Optics in its Series F Preferred Stock Financing for $32 Million with Johnson & Johnson Development Company acting as lead investor. ReVision Optics plans to use the money raised to fund commercialization.
- Flying L Ventures I, LLC Completes Series A Preferred Stock Financing Investment in Sightlife Surgical, Inc.On October 7, 2016 Stradling client Flying L Ventures I, LLC completed its investment of $10 million into Sightlife Surgical, Inc.’s Series A Preferred Stock Financing.
- ChoiceStream, Inc. Completes Subordinated Debt OfferingOn August 5, 2016, Stradling client ChoiceStream, Inc. completed an offering of subordinated secured debentures with accompanying preferred stock warrants to new and existing investors for a total purchase price of $6.5 million.
- Sequent Medical Completes Its Merger With Terumo CorporationStradling represented Sequent Medical, Inc. in its merger with a U.S. subsidiary of Terumo Corporation, a global medical device company. Under the terms of the deal, Terumo acquired Sequent in an all-cash transaction for $380 million ($280 million up front and up to an additional $100 million if certain milestones are achieved).
- Tenex, Inc. Closes Term Loan Facility From SWK FundingRepresented Tenex Health, Inc. in connection with its credit agreement with SWK Funding, which provides for $9 million of term loans to refinance existing indebtedness and for working capital.
- LogicMonitor, Inc. Closes $130 Million Investment by Providence Equity Partners L.L.C.Represented LogicMonitor, Inc. in a $130 million investment from Providence Strategic Growth (PSG), the growth equity affiliate of Providence Equity Partners, a global private equity firm with $45 billion in assets under management. The investment will be used to continue LogicMonitor’s global market expansion as the leading modern IT infrastructure performance monitoring solution.
- Healthcare Technology Capital Partners, LLC Completes Series A Preferred Stock Investment in i2i Systems, Inc.Represented Healthcare Technology Capital Partners, LLC, a newly formed investment fund, in its purchase of Series A preferred stock of i2i Systems, Inc. Stradling assisted with the formation of the newly formed investment fund and the investment by the fund in i2i Systems.
- Twining Inc. Completes Acquisition of Resources, Applications, Designs & Controls, Inc.Represented Twining, Inc. its acquisition of Resources, Applications, Designs & Controls, Inc., known as RADCO, for an undisclosed amount.
- Genea Energy Partners, Inc. Completes Series C Preferred Stock FinancingRepresented Genea Energy Partners, Inc. in its Series C Preferred Stock offering. Genea develops cloud-based software for the commercial real estate industry.
- ALPHAEON Corporation Completes Purchase of Series A Preferred Stock of Zelegent, Inc.Represented ALPHAEON Corporation in its purchase of shares of Series A Preferred Stock from Zelegent, Inc. to lead Zelgent’s Series A financing. Zelegent is a medical technology company that is developing, and plans to manufacture and market, innovative tools for physicians who treat sleep disorders.
- Synoptek Completes Sale of Its Majority Stake to Sverica Capital ManagementRepresented Synoptek Holdings, LLC in the sale of a majority stake in its operating company to Sverica Capital Management, a San Francisco-based private equity firm.
- ReShape Medical, Inc. Completes Offering of Its Series D Preferred Stock, Raising $38 MillionStradling client ReShape Medical, Inc. completed an offering of its Series D Preferred Stock to existing and new investors, including lead investor HealthCor Partners, for a total purchase price of approximately $38 million.
- Vertos Medical Raises $6 Million in Series 1 and 2 FinancingsRepresented Vertos Medical, Inc. in a round of Series 1 and Series 2 Preferred Stock Financing, raising approximately $6 million.
- WaveTec Vision Systems, Inc. Completes $350 Million SaleRepresented WaveTec Vision Systems, Inc., the developer of first commercialized intra-operative guidance system for enhanced cataract outcomes, in its $350 million sale to Alcon, the global leader in eye care and the second largest division of Novartis Group.
- ReShape Medical Receives $4 Million in Debt FinancingRepresented ReShape Medical in its $4 million debt financing to support its efforts to gain approval for a medical device to treat obesity.
- Tandem Diabetes Care, Inc. Completes $138 Million IPORepresented Tandem Diabetes Care, Inc., in its $138 Million IPO in 2013. It is listed on the Nasdaq under ticker symbol TNDM.
- Reach Pros Completes Equity Financing RoundRepresented Reach Pros in its equity financing round.
- Vertos Medical Raises $23 Million in Series E FinancingRepresented Vertos Medical, Inc. in its $23 million Series E Financing. The financing was led by Pitango Venture Capital and included existing investors, ONSET Ventures, CHL Medical Partners, Foundation Medical Partners, Mercury Fund and Aweida Venture Partners. The money raised will be used to fund U.S. commercialization and the launch of the mild® procedure in European Markets.
- Vessix Vascular Completes Its Sale to Boston Scientific CorporationStradling represented Vessix Vascular in its acquisition by Boston Scientific Corporation for up to $425 million.
- WaveTec Vision Systems Secures $16.5 Million in Venture Capital FinancingRepresented WaveTec Vision Systems, Inc. in securing $16.5 million in venture capital financing.
- Sequent Medical, Inc. Completes Its Series B Preferred Stock OfferingRepresented Sequent Medical, Inc. in its $15.6 million Series B Preferred Stock offering.
- Interventional Spine, Inc. Completes Its Series C Preferred Stock OfferingRepresented Interventional Spine, Inc. in its $24 million Series C Preferred Stock offering.
- YouMail, Inc. Completes Multiple Stock FinancingsRepresented YouMail, Inc. in multiple preferred stock financings.
- Powerwave Technologies, Inc. Secures Credit Facility With The Gores GroupSenior secured credit facility for Powerwave Technologies, Inc. (Nasdaq: PWAV) with The Gores Group – $50 million.
Education
- University of California, Los Angeles, J.D., corporate law specialization
- University of California, Los Angeles, B.A., history
Memberships & Associations
- Orange County Bar Association
- TriTech Small Business Development Center, Advisor
Bar Admissions
- California